CATALOGO DEI PRODOTTI DELLA RICERCA

DE MANZONI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.891
EU - Europa 12.545
AS - Asia 8.999
SA - Sud America 1.232
AF - Africa 362
Continente sconosciuto - Info sul continente non disponibili 355
OC - Oceania 36
AN - Antartide 1
Totale 38.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.542
RU - Federazione Russa 4.715
SG - Singapore 3.690
GB - Regno Unito 2.822
CN - Cina 2.546
IT - Italia 1.409
BR - Brasile 971
HK - Hong Kong 784
VN - Vietnam 745
DE - Germania 657
SE - Svezia 649
FR - Francia 615
IE - Irlanda 583
FI - Finlandia 454
KR - Corea 314
UA - Ucraina 174
CA - Canada 173
BD - Bangladesh 163
TR - Turchia 131
JP - Giappone 117
IN - India 103
NL - Olanda 89
NG - Nigeria 81
AR - Argentina 79
MX - Messico 79
ES - Italia 77
IQ - Iraq 60
ID - Indonesia 57
ZA - Sudafrica 56
AT - Austria 55
TG - Togo 48
PL - Polonia 45
EC - Ecuador 43
BE - Belgio 40
BJ - Benin 38
CO - Colombia 37
AU - Australia 32
UZ - Uzbekistan 31
PK - Pakistan 29
PY - Paraguay 28
VE - Venezuela 26
SA - Arabia Saudita 24
CZ - Repubblica Ceca 23
PH - Filippine 22
RW - Ruanda 22
EG - Egitto 21
JO - Giordania 21
LT - Lituania 21
IL - Israele 20
CL - Cile 19
AE - Emirati Arabi Uniti 18
KE - Kenya 18
IR - Iran 16
JM - Giamaica 15
MA - Marocco 15
KG - Kirghizistan 14
MY - Malesia 14
NO - Norvegia 14
UY - Uruguay 14
DZ - Algeria 12
HN - Honduras 12
PT - Portogallo 12
PA - Panama 11
TN - Tunisia 11
CR - Costa Rica 10
GR - Grecia 10
PE - Perù 10
AL - Albania 9
EU - Europa 9
LV - Lettonia 9
TT - Trinidad e Tobago 9
KZ - Kazakistan 8
TH - Thailandia 8
AO - Angola 7
AZ - Azerbaigian 7
BG - Bulgaria 7
ET - Etiopia 7
OM - Oman 7
TW - Taiwan 7
BB - Barbados 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
LB - Libano 6
RO - Romania 6
BY - Bielorussia 5
DK - Danimarca 5
PR - Porto Rico 5
PS - Palestinian Territory 5
SN - Senegal 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BH - Bahrain 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
MK - Macedonia 4
NI - Nicaragua 4
RS - Serbia 4
Totale 38.001
Salva come PNG Salva come JPEG
Città #
Southend 2.395
Singapore 1.955
Ashburn 1.724
San Jose 1.543
Moscow 1.511
Jacksonville 1.160
Chandler 1.142
Dallas 1.066
Hong Kong 776
Woodbridge 699
Verona 680
Dublin 578
Council Bluffs 547
Ann Arbor 460
Beijing 451
The Dalles 408
Houston 335
New York 322
Ho Chi Minh City 274
Los Angeles 259
Princeton 205
Lawrence 204
Wilmington 200
Jinan 182
Hanoi 164
Nanjing 157
Munich 141
Shenyang 140
Santa Clara 134
Redmond 133
Milan 132
Buffalo 122
Helsinki 111
Tokyo 104
Hebei 100
Sindelfingen 97
São Paulo 96
London 87
Redondo Beach 80
Abuja 78
Columbus 77
Tianjin 74
Changsha 69
Nanchang 62
Atlanta 60
Seoul 60
Zhengzhou 60
Guangzhou 56
Haikou 56
Seattle 54
Amsterdam 52
Chicago 52
Orem 52
Jiaxing 48
Lomé 48
Ningbo 47
Rome 47
Denver 46
Frankfurt am Main 46
Montreal 46
Phoenix 45
Brooklyn 44
Boardman 43
Stockholm 42
Brussels 40
San Francisco 40
Taizhou 39
Cotonou 38
Hangzhou 38
Warsaw 38
Toronto 36
Turku 36
Vienna 34
Johannesburg 33
Nuremberg 33
Rio de Janeiro 33
Boston 32
Dearborn 31
Norwalk 30
Madrid 29
McKinney 29
Mexico City 28
Baghdad 27
Manchester 27
Tashkent 26
Washington 26
Chennai 24
Haiphong 24
Providence 24
Lappeenranta 23
Ankara 22
Belo Horizonte 22
Jakarta 22
Kigali 22
Paris 22
Philadelphia 22
Taiyuan 22
Charlotte 21
Curitiba 21
Dong Ket 21
Totale 23.273
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 323
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 305
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 293
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 278
Genomic characterization of hepatoid tumors: context matters 272
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 263
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 261
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 234
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 234
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 233
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 219
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 216
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 216
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 215
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 213
Adenocarcinoma of the esophagogastric junction 212
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 212
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 210
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 206
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 205
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 204
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 203
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 202
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 200
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 200
Clinical pathways in gastric cancer care 199
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 198
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 197
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 196
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 195
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 193
Textbook outcome following oesophagectomy for cancer: international cohort study 192
Changing clinical and pathological features of gastric cancer over time. 191
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 191
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 188
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 187
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 186
Short-term and long-term risk factors in gastric cancer 185
A new way to experience the International Gastric Cancer Association congress: the Web Round Tables 184
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 184
Lymphadenectomy for gastric cancer at European specialist centres 183
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 182
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 181
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 179
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 179
Perianal Paget's disease: presentation of six cases and literature review. 178
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 177
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 177
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study 176
Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis 176
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 175
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 174
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] 173
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 172
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 172
Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus 171
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 170
Factors influencing survival after hepatectomy for metastases from gastric cancer 170
Experience on complex incisional hernia treatment in septic patients 170
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 167
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 167
[Patterns of transition between lymphangioma and intestinal lymphangiectasia. RAdiologic and histologic aspects of 2 cases with predominant involvement of the colon]. 167
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 167
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 165
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 165
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 165
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 164
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 164
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 164
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 164
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 163
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 163
Management of critically ill surgical patients Case reports 163
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 160
Complications after gastrectomy for cancer: Italian perspective 160
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 159
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 159
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery 158
Western strategy for EGJ carcinoma 157
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 157
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 156
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 156
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 155
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 155
Lymphadenectomy: how to do it? 155
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 155
Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery 153
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 153
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 152
Proximal Gastrectomy: Technical Notes 152
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 151
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 150
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 150
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 150
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 150
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 149
Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esofagus: impact of increased dosage on long-term results. 149
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 149
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 148
Totale 18.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.894
article - articoli 123.161
book - libri 1.800
conference - conferenze 7.058
curatela - curatele 0
other - altro 711
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.164
Totale 273.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 0 0 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20255.515 295 333 273 846 267 183 400 291 747 453 417 1.010
2025/202615.612 1.093 746 971 2.510 3.896 1.121 1.574 897 1.242 885 302 375
2026/20272.397 229 667 688 813 0 0 0 0 0 0 0 0
Totale 38.421